Efficacy of nanoTCEs in vivo. (A) Tumor progression and (B) Kaplan-Meier survival comparison between mice treated with Isotype/CD3 (grey; n = 5) or CD33/CD3 nanoTCEs (green; n = 5) (IMAGE)
Caption
Figure 4: Efficacy of nanoTCEs in vivo. (A) Tumor progression and (B) Kaplan-Meier survival comparison between mice treated with Isotype/CD3 (grey; n = 5) or CD33/CD3 nanoTCEs (green; n = 5). Statistical significance between CD33/CD3 and Isotype is indicated by *(p < 0.05). Tumor progression data is represented as mean ± standard deviation for tumor progression.
Credit
Correspondence to - Abdel Kareem Azab - kareem.azab@wustl.edu
Usage Restrictions
Credit must be given to the creator.
License
CC BY